JPH02290812A - Antiallergic fat and oil composition - Google Patents
Antiallergic fat and oil compositionInfo
- Publication number
- JPH02290812A JPH02290812A JP1111648A JP11164889A JPH02290812A JP H02290812 A JPH02290812 A JP H02290812A JP 1111648 A JP1111648 A JP 1111648A JP 11164889 A JP11164889 A JP 11164889A JP H02290812 A JPH02290812 A JP H02290812A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- fatty acid
- fats
- tea extract
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 230000003266 anti-allergic effect Effects 0.000 title claims abstract description 19
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 57
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 30
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 30
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 30
- 235000019197 fats Nutrition 0.000 claims abstract description 29
- 239000000284 extract Substances 0.000 claims abstract description 28
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 19
- 229930195729 fatty acid Natural products 0.000 claims abstract description 19
- 239000000194 fatty acid Substances 0.000 claims abstract description 19
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 19
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 15
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 15
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 12
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 11
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract description 11
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000470 constituent Substances 0.000 claims abstract description 6
- 239000004480 active ingredient Substances 0.000 claims abstract description 3
- 241001122767 Theaceae Species 0.000 claims 1
- 239000003921 oil Substances 0.000 abstract description 45
- 244000269722 Thea sinensis Species 0.000 abstract description 30
- 239000003925 fat Substances 0.000 abstract description 27
- 235000013305 food Nutrition 0.000 abstract description 7
- 239000003963 antioxidant agent Substances 0.000 abstract description 6
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 4
- 230000007815 allergy Effects 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- 240000008415 Lactuca sativa Species 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 239000002775 capsule Substances 0.000 abstract description 2
- 239000000839 emulsion Substances 0.000 abstract description 2
- 238000002347 injection Methods 0.000 abstract description 2
- 239000007924 injection Substances 0.000 abstract description 2
- 235000013310 margarine Nutrition 0.000 abstract description 2
- 239000003264 margarine Substances 0.000 abstract description 2
- 235000012045 salad Nutrition 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract description 2
- 235000019198 oils Nutrition 0.000 description 39
- 235000013616 tea Nutrition 0.000 description 24
- 230000000694 effects Effects 0.000 description 18
- 235000004347 Perilla Nutrition 0.000 description 13
- 241000229722 Perilla <angiosperm> Species 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 235000014593 oils and fats Nutrition 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 239000000944 linseed oil Substances 0.000 description 4
- 235000021388 linseed oil Nutrition 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000000224 granular leucocyte Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000000891 standard diet Nutrition 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 235000021195 test diet Nutrition 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- GWNVDXQDILPJIG-SHSCPDMUSA-N Leukotriene C4 Natural products CCCCCC=C/CC=C/C=C/C=C/C(SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C(O)CCCC(=O)O GWNVDXQDILPJIG-SHSCPDMUSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- LCFWOFKPFDWYLR-CEFNRUSXSA-N alpha-tocopheryloxyacetic acid Chemical compound OC(=O)COC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C LCFWOFKPFDWYLR-CEFNRUSXSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical group C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- GWNVDXQDILPJIG-NXOLIXFESA-N leukotriene C4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O GWNVDXQDILPJIG-NXOLIXFESA-N 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000010461 other edible oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229940092665 tea leaf extract Drugs 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- -1 α-linolenic acid Chemical class 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Edible Oils And Fats (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は,抗アレルギー性油脂組成物に関するものであ
る.
〔従来の技術〕
アレルギー症患者の増加の直接の原因が、カビ、花粉な
どのアレルゲンの増加のみに起因するのか,あるいは生
体の反応性の上昇によるのかは解明されていない.しか
し、必須脂肪酸バランスがアレルギーの症状に深く関わ
っているという根拠はある.奥山らにより,α−リノレ
ン酸を油脂の形で食品として摂取することによって,ア
レルギー反応の原因となるロイコトリエンの産生を抑制
する効果のあることは,すでに報告されている(奥山ら
. Prostaglandins., 36. 3(
1988) Lエイコサペンタエン酸およびドコサヘキ
サエン酸にも同様の作用が認められる.
ここで奥山らは、α−リノレン酸の動物実験では、飼料
中にα−リノレン酸を3重量%加えたもの(油脂として
は5重量%シソ油)を動物に与えて、アレルギー反応の
原因物質であるロイコトリエンの一種であるS R S
(slow reacting substance
)産生の抑制を確認している.SRSはロイコトリエン
C., D4. E,の混合物であり、気管支の筋肉を
収縮させる能力は、ヒスタミンやプロスタグランジンの
lOO〜1000倍も強力である.しかし、α−リノレ
ン酸は動物実験の結果によれば,かなりの量例えば20
重量%投与しないと効果が期待できないという問題点が
あった.〔発明が解決しようとする課題〕
本発明の目的は、上記問題点を解決するため、比較的少
量で抗アレルギー性を示し、天然物からなる経口投与可
能な抗アレルギー性油脂組成物を提供することである。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to an anti-allergic oil and fat composition. [Prior Art] It is not clear whether the direct cause of the increase in the number of allergic patients is due solely to an increase in allergens such as mold and pollen, or whether it is due to an increase in the reactivity of living organisms. However, there is evidence that essential fatty acid balance is deeply related to allergic symptoms. Okuyama et al. have already reported that ingesting α-linolenic acid in the form of fats and oils as food has the effect of suppressing the production of leukotrienes, which cause allergic reactions (Okuyama et al. Prostaglandins. 36.3(
(1988) Similar effects are observed for L-eicosapentaenoic acid and docosahexaenoic acid. In animal experiments on α-linolenic acid, Okuyama et al. found that animals were given feed containing 3% by weight of α-linolenic acid (5% by weight of perilla oil), and found that the causative agent of allergic reactions was SRS is a type of leukotriene.
(slow reacting substance
) suppression of production has been confirmed. SRS is leukotriene C. , D4. It is a mixture of E., and its ability to contract bronchial muscles is ~1000 times more powerful than histamine or prostaglandin. However, according to the results of animal experiments, α-linolenic acid is present in considerable amounts, e.g.
There was a problem that no effect could be expected unless the drug was administered in weight percent. [Problems to be Solved by the Invention] In order to solve the above-mentioned problems, an object of the present invention is to provide an orally administrable anti-allergic fat and oil composition that exhibits anti-allergic properties in a relatively small amount and is made of natural products. That's true.
本発明は、α−リノレン酸、エイコサペンタエン酸およ
びドコサヘキサエン酸から選ばれる脂肪酸を構成脂肪酸
として含む油脂と茶抽出物とを有効成分として含有する
ことを特徴とする抗アレルギー性油脂組成物である.
本発明では、α−リノレン酸、エイコサペンタエン酸、
ドコサヘキサエン酸等を含む油脂を主成分とし、これら
の作用をさらに強化する茶抽出物を加えることにより、
α−リノレン酸等や茶抽出物単独の場合よりも,はるか
に少ない量で効果のある抗アレルギー性油脂組成物が得
られる。The present invention is an anti-allergic oil composition characterized by containing as active ingredients an oil or fat containing a fatty acid selected from α-linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid as a constituent fatty acid, and a tea extract. In the present invention, α-linolenic acid, eicosapentaenoic acid,
The main ingredient is fats and oils containing docosahexaenoic acid, and by adding tea extract that further strengthens these effects,
An anti-allergic oil and fat composition that is effective can be obtained with a much smaller amount than when alpha-linolenic acid or tea extract is used alone.
本発明に用いる油脂はα−リノレン酸、エイコサベンク
エン酸およびドコサヘキサエン酸から選ばれる1種以上
の脂肪酸を構成脂肪酸として含む油脂である。これらの
油脂はα−リノレン酸、エイコサペンタエン酸およびド
コサヘキサエン酸の量に特に制限はないが、これらを総
脂肪酸の20重景%以上含むものが抗アレルギー効果の
点で好ましい。またリノール酸等の他の不飽和脂肪酸の
量は、α−リノレン酸、エイコサペンタエン酸およびド
コサヘキサエン酸より少ないほうが好ましい.α−リノ
レン酸を含む油脂としては、シソ油,エゴマ油、アマ二
油等が挙げられる。シソ油はシソ科植物の種子から、エ
ゴマ油はエゴマの種子から、アマ二油は亜麻の種子から
、圧搾法あるいは有機溶媒抽出法等の公知の方法により
得ら九る植物油である。従って本発明にかかわるこれら
の油脂組成物の原料としては、シソ油、エゴマ油または
アマ二油が用いられる.
またこれらのシソ油、エゴマ油またはアマ二油と他の食
用油、好ましくは植物油との混合油も原料として用いる
ことができる。The fats and oils used in the present invention are fats and oils containing one or more fatty acids selected from α-linolenic acid, eicosabencitric acid, and docosahexaenoic acid as constituent fatty acids. There are no particular restrictions on the amounts of α-linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid in these oils and fats, but those containing 20 weight percent or more of these fatty acids based on the total fatty acids are preferred from the viewpoint of anti-allergic effects. Further, the amount of other unsaturated fatty acids such as linoleic acid is preferably smaller than that of α-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid. Examples of fats and oils containing α-linolenic acid include perilla oil, perilla oil, and linseed oil. Perilla oil is a vegetable oil obtained from seeds of a plant belonging to the Lamiaceae family, perilla oil from perilla seeds, and linseed oil from flax seeds by a known method such as an expression method or an organic solvent extraction method. Therefore, perilla oil, perilla oil or linseed oil are used as raw materials for these oil and fat compositions according to the present invention. Moreover, a mixed oil of perilla oil, perilla oil, or linseed oil with other edible oil, preferably vegetable oil, can also be used as a raw material.
エイコサペンタエン酸およびドコサヘキサエン酸もα−
リノレン酸と同様のω−3脂肪酸であって同様な効果が
あり、これらを含む油脂を一部または全部をα−リノレ
ン酸に代えて使用することができる。エイコサベンタエ
ン酸およびドコサヘキサエン酸を含む油脂としては、イ
ワシ油,サンマ油,ニシン油などの魚油またはその濃縮
物がある。Eicosapentaenoic acid and docosahexaenoic acid are also α-
It is an omega-3 fatty acid similar to linolenic acid and has similar effects, and a part or all of oils and fats containing these can be used in place of α-linolenic acid. Examples of fats and oils containing eicosabentaenoic acid and docosahexaenoic acid include fish oils such as sardine oil, saury oil, and herring oil, or their concentrates.
本発明に用いる茶抽出物は茶菓、茶茎等から溶剤で抽出
したものである.溶剤としては、水、アルコール、アセ
トン、ヘキサン等いずれも効果があるが,特にアルコー
ルおよびアセトン抽出物が好ましい。The tea extract used in the present invention is extracted with a solvent from tea confections, tea stems, etc. As the solvent, water, alcohol, acetone, hexane, etc. are all effective, but alcohol and acetone extracts are particularly preferred.
これらの茶抽出物は、α−リノレン酸、エイコサペンタ
エン酸、ドコサヘキサエン酸等の抗アレルギー作用を強
化する作用を有し、両者の併用により優れた効果が得ら
れる。These tea extracts have the effect of enhancing the antiallergic effects of α-linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, etc., and excellent effects can be obtained by using both of them in combination.
α−リノレン酸、エイコサベンタエン酸、ドコサヘキサ
エン酸等の不飽和酸を多量に含む油脂は酸化安定性が悪
いが,茶抽出物はこれらの高度不飽和脂肪酸含有油脂の
抗酸化剤としても非常に有効であり、茶抽出物を加える
ことは、この面でも好都合である。一般に上記油脂はト
コフェロール等の抗酸化剤を添加して酸化防止されるが
、この場合でも茶抽出物を添加することにより抗アレル
ギー性が強化される。Oils and fats that contain large amounts of unsaturated acids such as α-linolenic acid, eicosabentaenoic acid, and docosahexaenoic acid have poor oxidation stability, but tea extract is also an excellent antioxidant for these oils and fats that contain highly unsaturated fatty acids. The addition of tea extract is also advantageous in this respect. Generally, the above-mentioned fats and oils are prevented from oxidizing by adding an antioxidant such as tocopherol, but even in this case, the anti-allergic properties are enhanced by adding a tea extract.
α−リノレン酸、エイコサペンタエン酸、ドコサヘキサ
エン酸を構成脂肪酸として含む油脂に加える茶抽出物の
量は0.02〜2重量%、好ましくは0.05〜2重量
%程度が最も実用的であり、この範囲で抗アレルギー効
果が得られる。The most practical amount of tea extract added to fats and oils containing α-linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid as constituent fatty acids is about 0.02 to 2% by weight, preferably about 0.05 to 2% by weight, Antiallergic effects can be obtained within this range.
本発明の抗アレルギー性油脂組成物は、α−リノレン酸
、エイコサペンタエン酸またはドコサヘキサエン酸を含
む油脂と茶抽出物を混合することによって得られる.こ
の場合,他の成分を配合することは差支えない.特にト
コフェロール等の他の抗酸化剤を配合することは,茶抽
出物の促進効果を維持する上で好ましい。The anti-allergic fat composition of the present invention is obtained by mixing a tea extract with an oil containing α-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid. In this case, there is no problem in adding other ingredients. In particular, it is preferable to incorporate other antioxidants such as tocopherol in order to maintain the promoting effect of the tea extract.
本発明の抗アレルギー性油脂組成物は、カプセル,錠剤
、乳液などとして、経口、注射等により投与してもよく
,またサラダ油やマーガリン等に混ぜて食品の形態で投
与してもよい.その投与量は大人1日当たり約0.5〜
30gである。The antiallergic fat composition of the present invention may be administered orally or by injection in the form of capsules, tablets, emulsions, etc., or may be administered in the form of food by mixing with salad oil, margarine, etc. The dosage is about 0.5~ per day for adults
It is 30g.
(発明の効果〕
本発明の抗アレルギー性油脂組成物は、アレルギーに対
して著しい抑制効果を有している。すなわち本発明では
、抗アレルギー効果の高いα−リノレン酸,エイコサペ
ンタエン酸またはドコサヘキサエン酸に茶抽出物を併用
したので,その相乗効果により著しく優れた抗アレルギ
ー効果を得ており、例えばα−リノレン酸等の含有量を
1/3にしても茶抽出物を加えることにより、同等の優
れた効果が得られる。(Effects of the Invention) The antiallergic oil and fat composition of the present invention has a remarkable suppressive effect on allergies. That is, the present invention uses α-linolenic acid, eicosapentaenoic acid, or docosahexaenoic acid, which has a high antiallergic effect. By using tea extract in combination, the synergistic effect results in a significantly superior anti-allergy effect. For example, even if the content of α-linolenic acid is reduced to 1/3, the same effect can be achieved by adding tea extract. Excellent effects can be obtained.
以下、実施例に基づき本発明を具体的に説明する.実施
例中、%は重量%である.
実施例1
(動物実験)
SD系雌ラット10匹を1群として、第1表に示す基準
食を用いて飼育して動物実験を行った.ここで第1表の
基準食中の脂肪分5%として、第2表に示す3種の油脂
(それぞれ抗酸化剤として300Pp麿のミックストコ
フェローノレ〔エーザイ(株)製〕をあらかじめ添加し
た)を使用し,それぞれの油脂に対して茶エキスを0.
5%添加した油脂組成物を与えた試験食群に分けて、1
2か月飼育した後解剖し,ラット腹腔から多形核白血球
(PMN)をCa−ionophora刺激して産生さ
れるSRS活性を測定した.SRS活性の測定は、片桐
ら、アレルギー、35, 936. 1986に記載さ
れた方法により,モルモット回腸を用いたバイオアッセ
イにて行った。The present invention will be specifically explained below based on Examples. In the examples, % is weight %. Example 1 (Animal experiment) An animal experiment was conducted by raising a group of 10 SD female rats using the standard diet shown in Table 1. Here, assuming that the fat content in the standard diet in Table 1 is 5%, the three types of oils and fats shown in Table 2 are added (300 Pp of mixed tocopherol [manufactured by Eisai Co., Ltd.] is added as an antioxidant to each). and add 0.0% tea extract to each oil and fat.
Divide into test food groups given 5% added oil and fat composition, 1
After being reared for 2 months, the rats were dissected and the SRS activity produced by Ca-ionophora stimulation of polymorphonuclear leukocytes (PMN) from the rat peritoneum was measured. Measurement of SRS activity is described by Katagiri et al., Allergy, 35, 936. A bioassay using guinea pig ileum was performed according to the method described in 1986.
第1表
第2表試験食群の油脂組成物
与えた油脂の脂肪酸組成を第3表に示す.第3表使用油
脂の脂肪酸組成(%)
使用した茶菓エキス抽出方法は次の通りである.エキス
の ゛
lkgの粉茶(緑茶を1〜2禦鳳程度に粋砕したもの)
に3ftのアセトンを加え、常温で一晩浸漬したのち濾
別し,濾液のアセトンをロータリーエバポレーターで留
去し、さらに減圧で風乾する.上記によるSRS活性測
定の結果を第1図に示す.
第1図の結果より、α−リノレン酸はトリグリセリド(
シソ油等)として摂取すると、SRSの産生を強く抑制
することが判る.この結果はすでに公知になっている報
告と同じであるが、これに茶菓エキスを加えることによ
り、α−リノレン酸のSRS産生抑制効果が著しく強化
されることが判る.この理由は明らかではないが,α−
リノレン酸のロイコトリエンC4.D4.E4生合成抑
制効果が、茶菓中の成分により、より一層強められるも
のと推測される.
実施例2
実施例1において、α−リノレン酸と茶菓エキスを適当
量ラット飼料中に添加することにより、著しいSRS産
生抑制効果のあることがわかったので、次に飼料中のα
−リノレン酸と茶菓エキスの含有量をどの程度まで下げ
ても実用的に有効かを見るための実験を行った。Table 1 Table 2 Fatty acid composition of test food group Table 3 shows the fatty acid composition of the given fats and oils. Table 3: Fatty acid composition of the oils and fats used (%) The tea confectionery extract extraction method used was as follows. 1kg of powdered tea extract (green tea crushed into 1-2 pieces)
Add 3 ft of acetone to the solution, soak overnight at room temperature, filter, remove acetone from the filtrate using a rotary evaporator, and air dry under reduced pressure. The results of the SRS activity measurement described above are shown in Figure 1. From the results shown in Figure 1, α-linolenic acid is triglyceride (
When ingested as perilla oil, etc.), it is found that SRS production is strongly suppressed. This result is the same as a previously known report, but it can be seen that by adding tea confectionery extract to this, the SRS production inhibiting effect of α-linolenic acid is significantly enhanced. The reason for this is not clear, but α−
Leukotriene C4 of linolenic acid. D4. It is presumed that the E4 biosynthesis inhibitory effect is further strengthened by the ingredients in the tea confectionery. Example 2 In Example 1, it was found that adding appropriate amounts of α-linolenic acid and tea confectionery extract to rat feed had a significant SRS production suppressing effect.
-An experiment was conducted to see to what extent lowering the contents of linolenic acid and tea confectionery extract would be practically effective.
(動物実験) 実施例1の動物実験と全く同じ方法を用いた。(Animal experimentation) Exactly the same method as in the animal experiment of Example 1 was used.
但し、試験食中の油脂組成物は第4表に示すように5群
とし、1群10匹でSD系雌ラットを用いて動物実験を
行った.
試験食の脂肪分はすべて5%とし,h群、i群のシソ油
の減少分は、リノール酸をほとんど含まない牛脂を加え
て全脂肪を5%に調整した.それぞれの油脂には実施例
1と同様に,抗酸化剤として300ppn+のミックス
トコフエロールをあらかじめ添加した.
第5表に各試験食の脂肪酸組成を示す。However, the oil and fat composition in the test diet was divided into 5 groups as shown in Table 4, and animal experiments were conducted using SD female rats with 10 animals per group. The fat content of all test meals was 5%, and the reduction in perilla oil in groups h and i was adjusted to 5% by adding beef tallow, which contains almost no linoleic acid. As in Example 1, 300 ppn+ mixed tocopherols were added in advance to each fat and oil as an antioxidant. Table 5 shows the fatty acid composition of each test meal.
試験食で飼育しはじめてから12か月後に解剖した結果
を第2図に示す。Figure 2 shows the results of dissection 12 months after the start of rearing on the test diet.
第2図の結果より、シソ油5%(α−リノレン酸3%)
、茶菓エキス0.3%の方が多少SRS産生抑制効果の
高い傾向はあるが、その差はわずかであり、いずれも有
意差はない.すなわち,α−リノレン酸の飼育中の含有
量を1.2%に下げても茶菓エキスを0.1%加えれば
,α−リノレン酸3%とほとんど同じ効果が得られるこ
とが判る。言いかえれば,α−リノレン酸と茶葉エキス
は抗アレルギー効果に関して相乗効果があることがわか
る.From the results in Figure 2, perilla oil 5% (α-linolenic acid 3%)
Although there is a tendency that 0.3% tea confectionery extract has a somewhat higher SRS production suppressing effect, the difference is small and there is no significant difference in either case. That is, it can be seen that even if the content of α-linolenic acid during rearing is lowered to 1.2%, adding 0.1% of tea confectionery extract can provide almost the same effect as 3% α-linolenic acid. In other words, it can be seen that α-linolenic acid and tea leaf extract have a synergistic effect regarding antiallergic effects.
第1図および第2@は実施例の結果を示すグラフである
.
代理人 弁理士 柳 原 成
第4表
試験食群の油脂組成物
第5表各試験食の脂肪酸組成(%)
第1図Figures 1 and 2 are graphs showing the results of Examples. Agent Patent Attorney Sei Yanagihara Table 4 Fat and oil composition of test food groups Table 5 Fatty acid composition of each test food (%) Figure 1
Claims (1)
コサヘキサエン酸から選ばれる脂肪酸を構成脂肪酸とし
て含む油脂と茶抽出物とを有効成分として含有すること
を特徴とする抗アレルギー性油脂組成物。(1) An anti-allergic oil or fat composition characterized by containing as active ingredients an oil or fat containing a fatty acid selected from α-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid as a constituent fatty acid, and a tea extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1111648A JPH02290812A (en) | 1989-04-28 | 1989-04-28 | Antiallergic fat and oil composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1111648A JPH02290812A (en) | 1989-04-28 | 1989-04-28 | Antiallergic fat and oil composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02290812A true JPH02290812A (en) | 1990-11-30 |
Family
ID=14566648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1111648A Pending JPH02290812A (en) | 1989-04-28 | 1989-04-28 | Antiallergic fat and oil composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02290812A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06192114A (en) * | 1991-01-25 | 1994-07-12 | Suntory Ltd | Medicine comprising extract of hydrangeae dulcis folium as active ingredient and food and cosmetic containing the same blended therein |
JPH06199688A (en) * | 1991-04-10 | 1994-07-19 | Woobang Land Co Ltd | Remedy composition for comedo |
JPH09121766A (en) * | 1995-10-31 | 1997-05-13 | Meiji Milk Prod Co Ltd | Food for infant having regulated n-6 series/n-3 series fatty acid ratio |
US6641846B2 (en) * | 2000-11-08 | 2003-11-04 | Tianjin Yanling Health Food Co. | Pharmaceutical composition against type I allergy and the preparation thereof |
US7384654B2 (en) | 2004-02-05 | 2008-06-10 | Access Business Group International Llc | Anti-Allergy composition and related method |
CN105028709A (en) * | 2015-08-24 | 2015-11-11 | 张廷杰 | Flaxseed seasoning oil |
CN109588501A (en) * | 2018-11-05 | 2019-04-09 | 大连大学 | A kind of antiallergy ready-mixed oil |
-
1989
- 1989-04-28 JP JP1111648A patent/JPH02290812A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06192114A (en) * | 1991-01-25 | 1994-07-12 | Suntory Ltd | Medicine comprising extract of hydrangeae dulcis folium as active ingredient and food and cosmetic containing the same blended therein |
JPH06199688A (en) * | 1991-04-10 | 1994-07-19 | Woobang Land Co Ltd | Remedy composition for comedo |
JPH09121766A (en) * | 1995-10-31 | 1997-05-13 | Meiji Milk Prod Co Ltd | Food for infant having regulated n-6 series/n-3 series fatty acid ratio |
US6641846B2 (en) * | 2000-11-08 | 2003-11-04 | Tianjin Yanling Health Food Co. | Pharmaceutical composition against type I allergy and the preparation thereof |
US7384654B2 (en) | 2004-02-05 | 2008-06-10 | Access Business Group International Llc | Anti-Allergy composition and related method |
US7384656B2 (en) | 2004-02-05 | 2008-06-10 | Access Business Group International Llc | Anti-allergy composition and related method |
CN105028709A (en) * | 2015-08-24 | 2015-11-11 | 张廷杰 | Flaxseed seasoning oil |
CN109588501A (en) * | 2018-11-05 | 2019-04-09 | 大连大学 | A kind of antiallergy ready-mixed oil |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2694054C (en) | Omega-3 fatty acid fortified composition | |
TWI331902B (en) | ||
CA2734477C (en) | Antioxidant composition for marine oils comprising tocopherol, rosemary extract, ascorbic acid and green tea extract, said green tea extract comprising a polysaccharide carrier | |
EP2170090A2 (en) | Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products | |
JP2005060334A (en) | Anti-obesity agent having lipase inhibiting activity and antioxidation activity | |
DE602004006860T2 (en) | CAPSAICINOID-CONTAINING PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
JPS6158536A (en) | Nutrient composition | |
US20120219647A1 (en) | Antioxidant composition | |
Aryee et al. | Perspectives on preserving lipid quality and strategies for value enhancement | |
US20180042978A1 (en) | Method of treating photo-induced ocular fatigue and associated reduction in speed of ocular focus | |
JP2006069948A (en) | Anti-aging composition and cosmetics, beverages and foods containing the same | |
JPH02290812A (en) | Antiallergic fat and oil composition | |
JP5309292B2 (en) | Lipase inhibitor | |
JPH09291299A (en) | Antiallergic oil and fat composition and use | |
KR20140116482A (en) | Organic emulsion comprising dha and epa | |
CN103284151A (en) | Omega-3 unsaturated vegetable combined oil with effect of reducing blood fat | |
TWI277422B (en) | Turmeric-containing composition | |
JP2002516285A (en) | Preparations based on artichoke plants, especially for use as pharmaceuticals or dietary supplements | |
JPH02113850A (en) | Oils and fats composition for carcinogenesis inhibition | |
JPH0542411B2 (en) | ||
JP2002302441A (en) | Composition and food and drink for obtunding symptom of premenstrual syndrome | |
JP2001302519A (en) | Antiobestic drug and method for producing the same | |
JPH0469614B2 (en) | ||
JPH0662795A (en) | Antiallergic food | |
RU2654868C1 (en) | Nutritional composition |